GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK

GlaxoSmithKline plc has announced the marketing authorisation of its quadrivalent (four-strain) influenza vaccine in Germany and the UK.
Source: GSK news - Category: Pharmaceuticals Source Type: news